This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Rheumatology, Other  • Women's Health, Other  • Genetic Disorders  • Immunologic Disorders  • Alert me on articles by topic

Tracy Hampton, PhD

JAMA. 2007;297:141-142.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Washington, DC—Sometimes called the "great imitator" because its symptoms vary so widely that it is often mistaken for other conditions, the autoimmune disease systemic lupus erythematosus puzzles and frustrates those seeking diagnostics and treatments for the disorder. But now, these efforts may be helped by research presented at the annual conference of the American College of Rheumatology and the Association of Rheumatology Health Professionals that is beginning to reveal some of the variables affecting disease onset, severity, and remission.

"Not only will we understand [lupus] better from this research, but it should lead ultimately to some kind of preventive strategy of overt disease," said Bevra Hahn, MD, of the University of California Los Angeles Medical Center.

Research is revealing some of the variables affecting aspects of systemic lupus, including disease onset, severity, and remission. (Photo credit: www.sciencesource.com)

In systemic lupus, which typically develops (without a . . . [Full Text of this Article]

AWAKENED X CHROMOSOME